| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/28/2001 | EP1077707A1 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis |
| 02/28/2001 | EP1077706A1 Ionophore containing composition for modulating amyloidosis |
| 02/28/2001 | EP1077705A1 Potassium channel agonists |
| 02/28/2001 | EP1077704A1 Combination therapy for treatment of depression |
| 02/28/2001 | EP1077703A1 Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates |
| 02/28/2001 | EP1077702A1 Peripheral benzodiazepine receptor ligands |
| 02/28/2001 | EP1077701A1 Anti-viral compounds |
| 02/28/2001 | EP1077700A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 02/28/2001 | EP1077699A1 Amide therapeutics for the treatment of inflammatory bowel disease |
| 02/28/2001 | EP1077698A1 Metabolites of ecteinascidin 743 |
| 02/28/2001 | EP1077697A1 Methods and assays useful in the treatment of alcohol dependence or alcohol abuse |
| 02/28/2001 | EP1077696A1 Furan nitrone therapeutics for the treatment of inflammatory bowel disease |
| 02/28/2001 | EP1077695A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES |
| 02/28/2001 | EP1077694A1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
| 02/28/2001 | EP1077692A1 Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
| 02/28/2001 | EP1077691A1 Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 02/28/2001 | EP1077690A1 Use of amyloid inhibitors for modulating neuronal cell death |
| 02/28/2001 | EP1077689A1 Acylpeptide protease inhibitors to enhance cognitive function |
| 02/28/2001 | EP1077688A1 Transdermal therapeutic system containing pergolide |
| 02/28/2001 | EP1077687A1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 02/28/2001 | EP1077685A2 Novel formulation containing paroxetine |
| 02/28/2001 | EP1077684A1 Effervescent preparations |
| 02/28/2001 | EP1077683A1 Antidepressant therapy |
| 02/28/2001 | EP1077682A2 Novel formulation containing paroxetine |
| 02/28/2001 | EP1077681A1 Pharmaceutical preparation containing levothyroxine sodium |
| 02/28/2001 | EP1077678A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 02/28/2001 | EP1077675A1 Therapeutic compositions |
| 02/28/2001 | EP1077616A1 Nutritional product for a person having renal failure |
| 02/28/2001 | EP0792879B1 Process for preparing 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate |
| 02/28/2001 | EP0706796B1 Dopamine re-uptake inhibitors for the treatment of parkinson's syndrome |
| 02/28/2001 | CN1285845A VEGI, an inhibitor of angiogenesis and tumor growth |
| 02/28/2001 | CN1285844A Compound |
| 02/28/2001 | CN1285843A Compound |
| 02/28/2001 | CN1285842A Compound |
| 02/28/2001 | CN1285841A Novel erythromycin derivatives |
| 02/28/2001 | CN1285838A Drugs, foods or drinks with the use of algae-derived physiologically active substances |
| 02/28/2001 | CN1285836A 3'-epimeric k-252a derivatives |
| 02/28/2001 | CN1285834A Fused pyrazine compound |
| 02/28/2001 | CN1285831A Substituted thiezolidinedione derivative, process for its preparation and pharmaceutical use |
| 02/28/2001 | CN1285829A Method for producing doxazodin mesylate in crystal modification designated as form A and intermediate product for producing the same |
| 02/28/2001 | CN1285828A Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 02/28/2001 | CN1285825A Novel allylthiopyridazine derivatives and process for preparing the same |
| 02/28/2001 | CN1285823A Phenyl-alkyl-imidazoles as H3 receptor antagonists |
| 02/28/2001 | CN1285822A H receptor ligands of phenyl-alkyl-imidazoles type |
| 02/28/2001 | CN1285821A Aryl Fused azapolycyclic compounds |
| 02/28/2001 | CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 02/28/2001 | CN1285818A Compound for antemortem diagnosis of alzheimer's disease and i(IN VIVO) imaging and prevention of amyloid deposition |
| 02/28/2001 | CN1285817A Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 02/28/2001 | CN1285751A Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 02/28/2001 | CN1285750A New composition of matter |
| 02/28/2001 | CN1285749A Penetration enhancing and irritation reducing systems |
| 02/28/2001 | CN1285748A Use of 9-deoxy-2', 9-alpha-methano-3-oxa-4,5,6-trinor-3, 7-(1,'3'-interphenylene)-13, 14-dihydro-prostaglandin F, to treat peripheral vascular disease |
| 02/28/2001 | CN1285747A Combination therapy for treating AIDS |
| 02/28/2001 | CN1285746A Method and composition of an oral preparation of itraconazole |
| 02/28/2001 | CN1285745A Application of enzyme products as anti-infective agents |
| 02/28/2001 | CN1285744A Use of histamine for elevating blood histamine levels |
| 02/28/2001 | CN1285743A Process for production of arsenic trioxide formulations and methods for treating cancer using arsenic troxide or melarsoprol |
| 02/28/2001 | CN1285742A Combination of active principles for treating senile dementia such as alzheimer dementia |
| 02/28/2001 | CN1285741A Double capsule for the administration of active principles in multiple therepies |
| 02/28/2001 | CN1285739A High drug load immediate and modified release oral dosage formulations and process for their production |
| 02/28/2001 | CN1285738A Novel oral dosage form for carvedilol |
| 02/28/2001 | CN1285352A Preparation for lignal like material |
| 02/28/2001 | CN1285351A Taxane with alkyl subtituted lateral chain and medicinal composition containing said compound |
| 02/28/2001 | CN1285345A Sertraline and its salt, and its usage for treating mammal premature ejaculation |
| 02/28/2001 | CN1285220A Powder medicine made of Chinese and Western medicines for treating toothache and preparation process thereof |
| 02/28/2001 | CN1285211A Formula of medicine for treating myopia and preparation process thereof |
| 02/28/2001 | CN1285201A Medicine for warming kidney and treating wind-dampness syndrome and preparation process thereof |
| 02/28/2001 | CN1285200A External medicine for treating sore caused by shell wound all bullet wound |
| 02/28/2001 | CN1285196A Shubi plaster for treating arthralgia due to wind-cold-dampness |
| 02/28/2001 | CN1285194A Crustaceous extract health care foods and preparation method thereof |
| 02/28/2001 | CN1285193A preparing and application of oral hyaluronic acid skin-beautifying health care preparation |
| 02/28/2001 | CN1285192A Process for preparation of coated azithromycin micropill |
| 02/28/2001 | CN1285191A Medicine for treating epidemic poultry and animal diseases |
| 02/28/2001 | CN1285190A Application of isogorgonian acid in pharmacy |
| 02/28/2001 | CN1285189A Fluoxetine enteric soluble micro-capsule |
| 02/28/2001 | CN1285188A Thermal formed solid releasing-controlled medicinal composition |
| 02/28/2001 | CN1062562C Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
| 02/28/2001 | CN1062561C 7-halo-and 7beta, 8 beta-methano-taxols, antineoplastic use and pharmaceutical compositions containing them |
| 02/28/2001 | CN1062555C Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
| 02/28/2001 | CN1062554C Substituted guanidine cinnamate, its prepn., its application as medicine or diagnosing agent and medicine containing the compound |
| 02/28/2001 | CN1062552C Cyclohexadiene derivatives, pharmaceuticals contg. same, prepn. method and use thereof |
| 02/28/2001 | CN1062549C Process for the pheparation of allyl quinone derivatives, and intermediates |
| 02/28/2001 | CN1062469C Privates-cleaning effervescence preparation and preparation process thereof |
| 02/28/2001 | CN1062467C Clean-keeping agent and moisture-retaining tissue |
| 02/28/2001 | CN1062449C Method for preparation of fodder used in cultivating crustacea |
| 02/28/2001 | CN1062445C Medicinal composition capable of contraception by killing sperm, and disinfection and reducing inflammation for preventing venereal disease |
| 02/28/2001 | CN1062444C Process for preparation of oral slow-release controlled composition |
| 02/28/2001 | CA2317097A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2317001A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2316748A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/27/2001 | USRE37078 Antiinflammatory agents, antiarthritic agents |
| 02/27/2001 | USRE37077 Adenosine derivatives and pharmaceutical composition thereof |
| 02/27/2001 | US6194601 5,6-dihydronaphthalenyl derivatives having retinoid-like activity |
| 02/27/2001 | US6194598 Aminooxy-modified oligonucleotide synthetic intermediates |
| 02/27/2001 | US6194592 As antimycotic agent |
| 02/27/2001 | US6194585 Process for preparing 5-lipoxygenase inhibitors |
| 02/27/2001 | US6194579 Providing quantity of 7-keto camptothecin; selectively substituting leaving group at c7 carbon of 7-keto camptothecin; selectively derivatizing c7 carbon |
| 02/27/2001 | US6194574 Selectively bind to corticotropin-releasing factor (crf1) receptors; for treating stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety |
| 02/27/2001 | US6194565 Antiinflammatory agent |
| 02/27/2001 | US6194493 4-hydroxyquinoline-3-carboxylic acid derivatives as light stabilizers |